Want to join the conversation?
Animas, part of $JNJ, said that FDA has approved use of Animas Vibe Insulin Pump and Continuous Glucose Monitoring (CGM) System for the management of diabetes in children and adolescents, ages 2 to 17. The Animas Vibe System allows patients and their caregivers to view glucose data and administer insulin right from pump.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.